The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Racial and socioeconomic disparities in overall survival in colorectal cancer (CRC) at West Cancer Center (WCC), Memphis, TN.
 
Vanessa Wookey
No Relationships to Disclose
 
Gabriella Bufalino
No Relationships to Disclose
 
Gregory A. Vidal
Consulting or Advisory Role - Genentech; Genentech; Genentech; Genentech; Immunomedics; Immunomedics; Immunomedics; Immunomedics; Lilly; Lilly; Lilly; Lilly; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Lilly; Lilly; Lilly; Lilly; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology
Research Funding - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celcuity; Celcuity; Celcuity; Celcuity; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Lilly; Lilly; Lilly; Lilly; Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics; Pfizer; Pfizer; Pfizer; Pfizer; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology; Tesaro; Tesaro; Tesaro; Tesaro
 
Bradley G. Somer
No Relationships to Disclose
 
Lee S. Schwartzberg
Stock and Other Ownership Interests - Vector Oncology; Vector Oncology; Vector Oncology; Vector Oncology
Honoraria - Amgen; Amgen; Amgen; Amgen; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; E.R. Squibb Sons, LLC; E.R. Squibb Sons, LLC; E.R. Squibb Sons, LLC; E.R. Squibb Sons, LLC; Genentech; Genentech; Genentech; Genentech; Genomic Health; Genomic Health; Genomic Health; Genomic Health; Helsinn Healthcare; Helsinn Healthcare; Helsinn Healthcare; Helsinn Healthcare; Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics; NanoString Technologies; NanoString Technologies; NanoString Technologies; NanoString Technologies; Napo Pharmaceuticals; Napo Pharmaceuticals; Napo Pharmaceuticals; Napo Pharmaceuticals; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Amgen; Amgen; Amgen; Amgen; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Athenex; Athenex; Athenex; Athenex; Biocept; Biocept; Biocept; Biocept; bioTheranostics; bioTheranostics; bioTheranostics; bioTheranostics; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Coherus Biosciences; Coherus Biosciences; Coherus Biosciences; Coherus Biosciences; E.R. Squibb Sons, LLC; E.R. Squibb Sons, LLC; E.R. Squibb Sons, LLC; E.R. Squibb Sons, LLC; Genentech; Genentech; Genentech; Genentech; Genomic Health; Genomic Health; Genomic Health; Genomic Health; Helsinn Therapeutics; Helsinn Therapeutics; Helsinn Therapeutics; Helsinn Therapeutics; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals; Tesaro; Tesaro; Tesaro; Tesaro
Speakers' Bureau - Coherus Biosciences; Coherus Biosciences; Coherus Biosciences; Coherus Biosciences; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Bayer Health (Inst); Bayer Health (Inst); Bayer Health (Inst); Bayer Health (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics; Helsinn Therapeutics; Helsinn Therapeutics; Helsinn Therapeutics; MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Medivation (Inst); Medivation (Inst); Medivation (Inst); Medivation (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Spectrum Pharmaceuticals (Inst); Spectrum Pharmaceuticals (Inst); Spectrum Pharmaceuticals (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst)
 
Axel Grothey
Honoraria - Aptitude Health; Aptitude Health; Aptitude Health; Aptitude Health; Elsevier; Elsevier; Elsevier; Elsevier; IMEDEX; IMEDEX; IMEDEX; IMEDEX
Consulting or Advisory Role - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Guardant Health (Inst); Guardant Health (Inst); Guardant Health (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst)
Research Funding - Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme